These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16401650

  • 1. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.
    Veldhuijzen DS, van Wijck AJ, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, Volkerts ER.
    J Psychopharmacol; 2006 Nov; 20(6):782-8. PubMed ID: 16401650
    [Abstract] [Full Text] [Related]

  • 2. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG.
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [Abstract] [Full Text] [Related]

  • 3. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.
    Verster JC, Bekker EM, de Roos M, Minova A, Eijken EJ, Kooij JJ, Buitelaar JK, Kenemans JL, Verbaten MN, Olivier B, Volkerts ER.
    J Psychopharmacol; 2008 May; 22(3):230-7. PubMed ID: 18308788
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.
    Ramaekers G, Lamers J, Verhey F, Muntjewerff D, Mobbs E, Sanders N, Lewis M, Lockton A.
    Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350
    [Abstract] [Full Text] [Related]

  • 5. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.
    Iwamoto K, Kawamura Y, Takahashi M, Uchiyama Y, Ebe K, Yoshida K, Iidaka T, Noda Y, Ozaki N.
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):610-6. PubMed ID: 18950383
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW, Volkerts ER, van Willigenburg AP.
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [Abstract] [Full Text] [Related]

  • 7. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY, Huh BK, White WD, Yeh CC, Miller EJ.
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [Abstract] [Full Text] [Related]

  • 8. Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
    Ramaekers JG, Kuypers KP, Samyn N.
    Addiction; 2006 Nov; 101(11):1614-21. PubMed ID: 17034441
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
    Sennef C, Timmer CJ, Sitsen JM.
    Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic nonmalignant pain on highway driving performance.
    Veldhuijzen DS, van Wijck AJ, Wille F, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, Volkerts ER.
    Pain; 2006 May; 122(1-2):28-35. PubMed ID: 16495013
    [Abstract] [Full Text] [Related]

  • 11. Acute and subchronic effects of amitriptyline on processing capacity in neuropathic pain patients using visual event-related potentials: preliminary findings.
    Veldhuijzen DS, Kenemans JL, van Wijck AJ, Olivier B, Kalkman CJ, Volkerts ER.
    Psychopharmacology (Berl); 2006 Jan; 183(4):462-70. PubMed ID: 16292592
    [Abstract] [Full Text] [Related]

  • 12. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood.
    Verster JC, Veldhuijzen DS, Volkerts ER.
    Clin J Pain; 2006 Jun; 22(5):499-504. PubMed ID: 16772806
    [Abstract] [Full Text] [Related]

  • 13. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
    Kautio AL, Haanpää M, Saarto T, Kalso E.
    J Pain Symptom Manage; 2008 Jan; 35(1):31-9. PubMed ID: 17980550
    [Abstract] [Full Text] [Related]

  • 16. The effect of nabilone on neuropsychological functions related to driving ability: an extended case series.
    Kurzthaler I, Bodner T, Kemmler G, Entner T, Wissel J, Berger T, Fleischhacker WW.
    Hum Psychopharmacol; 2005 Jun; 20(4):291-3. PubMed ID: 15834843
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
    van Laar MW, Volkerts ER, Verbaten MN, Trooster S, van Megen HJ, Kenemans JL.
    Psychopharmacology (Berl); 2002 Aug; 162(4):351-63. PubMed ID: 12172688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
    Conen S, Theunissen EL, Van Oers AC, Valiente R, Ramaekers JG.
    J Psychopharmacol; 2011 Nov; 25(11):1517-23. PubMed ID: 20855350
    [Abstract] [Full Text] [Related]

  • 20. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
    van de Loo AJAE, Bervoets AC, Mooren L, Bouwmeester NH, Garssen J, Zuiker R, van Amerongen G, van Gerven J, Singh J, der Ark PV, Fedgchin M, Morrison R, Wajs E, Verster JC.
    Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.